Advertisement
Australia markets closed
  • ALL ORDS

    7,806.00
    -92.90 (-1.18%)
     
  • ASX 200

    7,555.70
    -86.40 (-1.13%)
     
  • AUD/USD

    0.6401
    -0.0025 (-0.39%)
     
  • OIL

    83.99
    +1.26 (+1.52%)
     
  • GOLD

    2,397.30
    -0.70 (-0.03%)
     
  • Bitcoin AUD

    96,882.22
    +1,302.98 (+1.36%)
     
  • CMC Crypto 200

    1,281.09
    -31.54 (-2.40%)
     
  • AUD/EUR

    0.6017
    -0.0014 (-0.23%)
     
  • AUD/NZD

    1.0886
    +0.0011 (+0.10%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,837.40
    +67.38 (+0.38%)
     
  • Hang Seng

    16,175.76
    -210.11 (-1.28%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.65%)
     

GE HealthCare begins trading on the Nasdaq

Yahoo Finance Live anchors discuss GE HealthCare completing its spin-off from General Electric.

Video transcript

ANAJLEE KHEMLANI: Well, let's get to my pick. GE has finally spun off its health unit, creating the newly listed GE Healthcare on the NASDAQ, which began trading today. The parent GE will still have nearly a 20% stake in the spinoff. And while this isn't a new business line for GE, it does signal the appeal of an industry that accounts for nearly 20% of the country's GDP. Between the influx of tech and other consumer brands in recent years, everyone is wrangling for their piece of the $4 trillion pie. I feel like I talk about this all the time.

Tracking-- while tracking tech and technology sectors' attempts to infiltrate the space has been top of mind for investors, brands like Best Buy, you see retail pharmacies and others that you recognize. As you can see on your screen, Lyft, Uber, UPS, you wouldn't think, has its own health unit. So increasingly, these companies are trying to find new avenues to capitalize on what is a sector that just won't quit.

ADVERTISEMENT

Medtech especially, which often covers devices, is an area of growth as more companies tinker with the idea of consumer-facing health devices. That came, of course, we saw during the pandemic, more remote monitoring, more wearables. And so these companies are really trying to get in on that space.

Meanwhile, you've got legacy medtech sector, the medtech-- medtech sector-- wow, I didn't realize I was going to have that tongue twister in there-- dominated by big pharma. Think of J&J and Medtronic and the like. That's going to be really interesting to watch because they have been watching consumer habits.

And you've seen some of these big players spin out or not pay as much attention to consumer brands, but also what consumers demand as patients, whether in the outpatient setting or when you're looking at remote monitoring wearables and the like. That's really going to drive the strategy of these companies, I think, in the coming years.

DAVE BRIGGS: And the company, some feel, will be worth some $50 billion. This is going to be a huge spinoff. And really, the story of GE moving forward is going to be one of the stories of the year, in particular, the shedding of its power business. My eye's on GE Aerospace, the one that's worth the most money, somewhere in the neighborhood of $100 billion, they believe, spinning out more than $20 billion annually in revenue.